Lind Kevin Robert 4
4 · Avalo Therapeutics, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Lind Kevin Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+40,200→ 40,200 totalExercise: $12.96Exp: 2035-10-01→ Common Stock (40,200 underlying)
Footnotes (1)
- [F1]The stock option vests in three substantially equal installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.